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Threats to the effectiveness of insecticide-treated bednets 
for malaria control: thinking beyond insecticide resistance
Steve W Lindsay, Matthew B Thomas, Immo Kleinschmidt
From 2004 to 2019, insecticide-treated bednets (ITNs) have been the most effective tool for reducing malaria morbidity 
and mortality in sub-Saharan Africa. Recently, however, the decline in malaria cases and deaths has stalled. Some 
suggest that this inertia is due to increasing resistance in malaria vectors to the pyrethroid insecticides used for 
treating ITNs. However, there is presently little evidence to reach this conclusion and we therefore recommend that a 
broader perspective to evaluate ITN effectiveness in terms of access to nets, use of nets, bioefficacy, and durability 
should be taken. We argue that a single focus on insecticide resistance misses the bigger picture. To improve the 
effects of ITNs, net coverage should increase by increasing funding for programmes, adopting improved strategies 
for increasing ITN uptake, and enhancing the longevity of the active ingredients and the physical integrity of nets, 
while simultaneously accelerating the development and evaluation of novel vector control tools.
Introduction
From 2004 to 2019, a major malaria control campaign 
based on insecticide-treated bednets (ITNs), indoor 
residual spraying (IRS), and prompt and effective 
treatment with antimalarials, prevented an estimated 
1·2 billion malaria cases and 7·1 million deaths in sub-
Saharan Africa.1 By far the most important contribution 
was due to ITNs, responsible for an estimated 68% of the 
cases averted.2 The scale of their deployment in sub-
Saharan Africa has been huge, with 1·9 billion ITNs 
supplied to the region from 2004 to 2019.1 Despite this 
massive roll-out, in 2019, only 36% of households owned 
at least one bednet for every two persons, increasing 
from a mere 1% in 2000. Although still falling well short 
of the target of providing protection against malaria for 
all who are at risk, this coordinated campaign has been a 
remarkable achievement. Unfortunately, since 2015, the 
decline in malaria has stalled, with WHO’s African 
region failing to meet the 2020 Global Technical Strategy 
milestones for malaria morbidity by 37% and malaria 
mortality by 25%.1 A major concern has been that 
resistance to insecticides used on the nets in malaria 
mosquitoes has caused the decline in malaria to plateau. 
Consequently, WHO has focused considerable efforts to 
monitor the presence of insecticide resistance in vector 
populations around the globe.3 Further, the threat of 
resistance has shaped international malaria control 
policy, and drives much of the investment in research 
and development for vector control tools, eclipsing other 
factors that also affect the effectiveness of ITNs. In this 
Viewpoint, we aim to broaden discussion beyond the 
single threat of resistance and stimulate consideration of 
a more comprehensive suite of factors that affect the 
current effectiveness of ITNs and contribute to the 
stalling progress towards malaria eradication. Technical 
terms used in the article are explained in panel 1 and how 
ITNs work in panel 2.
Insecticide resistance
Until the last very years, the only insecticides used 
for ITNs were pyrethroids, such as permethrin 
and deltamethrin, which are highly lethal to susceptible 
mosquitoes after even transient contact. Evolutionary 
theory, however, tells us that sustained use of a toxic 
substance that reduces the fitness of an organism will 
probably select for resistance. Over time, providing 
the toxin pressure is maintained, resistant individuals 
will spread through the population. In line with this 
expectation, resistance against pyrethroid insecticides 
was first detected in Anopheles gambiae, sub-Saharan 
Africa’s principal malaria vector, in Côte d’Ivoire 
in 1993,4 and is now widespread throughout the region. 
There are few, if any countries, where malaria vector 
populations remain fully susceptible.5
The effect of pyrethroid resistance on malaria control 
has been a primary concern for over 20 years.6 Yet in 
spite of the rapid and predictable evolution of resistance 
in response to widescale deployment of ITNs, evidence 
of control failure due to physiological resistance against 
ITNs is mixed. Many laboratory and semi-field studies 
show that ITNs have less instantaneous effect on 
mortality and blood feeding of resistant mosquitoes than 
susceptible populations.7,8 These entomological studies 
provide valuable insights into the potential effect of 
resistance on performance of ITNs, but they do not tell 
us what the effect of resistance might be on overall 
malaria transmission at the community level. To address 
this limitation one study9 used entomological data 
from multiple small scale, short-term experiments to 
parameterise a mathematical model of transmission. 
The study9 suggested that increasing levels of resistance 
in vector populations would increase both the number of 
clinical malaria cases and the force of infection. The 
magnitude of the effect, however, was sensitive to the 
effective coverage of ITNs (ie, what proportion of 
the population owned and used a net). This result was 
further supported by a separate modelling study that 
indicated that at moderate levels of effective coverage 
(ie, >50%), the effect size of resistance on overall trans-
mission could be very small.10 Therefore, although 
laboratory and semi-field studies raise justifiable 
concern, how resistance plays out at community level in 
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the field is less clear. This conclusion is further supported 
by epidemiological data from sub-Saharan Africa.11-13
To date, there are no convincing examples of insecticide 
resistance rendering ITNs ineffective in sub-Saharan 
Africa. In 2014, a systematic review and meta-analysis14 of 
36 laboratory and 24 field studies found that ITNs were 
more effective than untreated bednets irrespective of 
the level of resistance. A similar analysis15 published 
in 2019 reported a 60% reduction in the odds of malaria 
associated with ITN use.15 A study in Malawi showed 
that net use was associated with a 30% reduction in 
the incidence of malaria infection compared to non-net 
use, despite high levels of insecticide resistance in the 
major malaria vectors.11 In Kenya, net users were also 
protected with 39% lower infection rates in areas of low 
resistance and 45% lower in high resistant areas, than 
were non-net users.12
The largest and most comprehensive study13 to date 
was a WHO-led multi-country study done in Benin, 
Cameroon, India, Kenya, and Sudan. Approximately 
40 000 children were followed up and the vector control 
tool used was ITNs, apart from Sudan where ITNs were 
combined with indoor residual spraying. Children who 
slept under ITNs had a 37% reduced risk of infection 
with Plasmodium falciparum and 38% lower incidence of 
clinical malaria than did non-users across a range of 
different insecticide intensities. There was no evidence 
of an association between levels of insecticide resistance 
and protection against malaria provided by nets. Again, 
the conclusion is that ITNs continue to provide control 
benefits for users in spite of insecticide resistance.
Two randomised controlled trials16,17 have been done in 
areas with high levels of insecticide-resistant vectors, 
using next generation ITNs with novel modes of action 
designed to mitigate pyrethroid resistance. In Tanzania, 
a trial16 of nets with a pyrethroid plus piperonyl butoxide, 
a synergist that disrupts the capacity of mosquitoes to 
detoxify pyrethroids, showed a 63% reduction in the odds 
of malaria infections compared with pyrethroid only 
nets. In Burkina Faso, a trial17 of nets with a pyrethroid 
plus pyriproxyfen, an insect growth regulator, showed 
enhanced protection against clinical malaria than with 
conventional pyrethroid nets.17 Taken at face value, these 
results might suggest that the combination nets are 
resistance-breaking and thereby provide a measure of the 
effect of resistance on control with standard nets. An 
alternative, and more parsimonious explanation, is that 
the combination nets are simply more toxic than 
pyrethroids alone and would be similarly efficacious if 
used against susceptible (or resistant) vector populations. 
For example, when a susceptible strain of the mosquito, 
Culex pipiens pallens, was tested against a range of 
pyrethroids, knockdown and mortality increased sharply 
with the addition of piperonyl butoxide.18 More over, the 
combination nets used in these field trials19,20 had 
increased bioavailability of the pyrethroid on the net 
surface compared with the standard net. The combination 
nets tested to date are likely to be more insecticidal than 
standard ITNs, irrespective of whether the vectors are 
resistant or susceptible.
Why ITNs can remain protective against 
resistant mosquitoes
The evidence taken together suggests that insecticide 
resistance is not presently having a substantial effect 
on malaria control. Why might this be the case? First, 
intact ITNs are a physical barrier to mosquitoes and 
even untreated nets provide personal protection against 
malaria provided they are undamaged.21 Second, there 
may be sublethal effects of exposure to pyrethroids, such 
as increased irritancy on contact with treated netting, 
decreasing the exposed mosquito’s ability to find and feed 
on a host,10 or incubate malaria parasites.22,23 Third, 
resistance might reduce vector competence in the absence 
of insecticide exposure with malaria infection reducing 
survival only in insecticide-resistant mosquitoes, but not 
in susceptibles.24,25 Fourth, resistant mosquitoes can be 
Panel 1: Glossary of terms
Definitions used by WHO
• Bioefficacy: refers to insecticidal activity and is a measure of knockdown, mortality, or 
inhibition of blood feeding induced in mosquitoes recorded in a WHO test such as a 
cone bioassay or tunnel test.
• Durability: considers the combination of net survivorship, fabric integrity, and 
insecticidal activity (bioefficacy).
• Effective coverage: is the fraction of the population that use insecticide-treated 
bednets.
• Entomological inoculation rate: number of infective bites received per person in a 
given unit of time in a human population.
• Functional survival: is the proportion of insecticide-treated bednets in good or 
acceptable condition at time (x) expressed as a percentage of insecticide-treated 
bednets originally received and not given away at time (x).
• Insecticide resistance: property of mosquitoes to survive exposure to a standard dose 
of insecticide; may be the result of physiological or behavioural adaptation.
• Insecticidal activity (bioefficacy): is the degree of knockdown, mortality, or inhibition of 
blood feeding induced in susceptible mosquitoes, as determined by standard WHO test 
procedures and criteria (ie, cone bioassay and tunnel test). Insecticidal activity is 
associated with the type and content or availability of insecticide. The insecticide content 
is expressed as g/kg or mg/m2 of the insecticide-treated bednets and is determined by the 
method outlined in WHO specifications for insecticide-treated bednets. This information 
is of value in interpreting data on bioefficacy. Insecticidal activity can be assessed as a 
function of length of use.
• Knockdown: for insecticide bioassays, a knockdowned mosquito is one that cannot stand 
(eg, has one or two legs), cannot fly in a coordinated manner, lies on its back, moving 
legs and wings but unable to take off or one that can stand and take off briefly but falls 
down immediately.
• Mortality: for insecticide bioassays, it is a mosquito that shows no sign of life, is 
immobile and cannot stand.
• Physical (fabric) integrity: reflects the number, location, and size of holes in each net.
• Survivorship: is the proportion of distributed nets still available for use as intended in the 
households to which they were given after a defined period (eg, 1, 2, or 3 or more years).
• Universal coverage: is access to and use of nets by the entire population at risk of malaria.
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less fit than susceptible ones,26,27 reducing their overall 
survival, and hence reducing the number of older and 
therefore infective mosquitoes. Overall, these factors 
operate to produce complex interactions that are likely to 
dilute the effect of insecticide resistance on the 
effectiveness of ITNs.
The way insecticide resistance is commonly assessed 
might further obscure the demonstration of a link 
between resistance and effect on vector control. WHO’s 
standard discriminating dose bioassay28 is designed to 
detect the early stages of resistance in vector populations, 
not to infer anything about implications for control. 
The standard assays expose 3–5-day-old, non-blood-fed 
mosquitoes in a small tube lined with paper treated with 
insecticide at twice the concentration required to kill 
100% of susceptible mosquitoes. After 60 min exposure 
the mosquitoes are removed and assessed for mortality, 
and then assessed again after 24 h. A mosquito population 
is characterised as resistant if it displays less than 
90% mortality at 24 h. In real life, mosquitoes vary in 
age, blood-feeding status and frequency and intensity 
of previous exposure to insecticide. Video studies29 on 
mosquitoes approaching a human-occupied net show that 
mosquito contact with an ITN is brief, with an average 
duration of 7 s—orders of magnitude shorter than the 
WHO bioassay. Additionally, mosquitoes contact the net 
differently as they land and attempt to feed and can contact 
a treated net on multiple occasions over their lifetime. The 
net itself has a higher dose of insecticide than used in the 
tube test (although this will vary depending on the age of 
the net and the wash history). To assess these effects 
studies30 have attempted to develop more realistic assays 
that allow mosquitoes to search for a host and contact an 
ITN on multiple occasions.30 This research suggests that 
substantial mortality can occur even in highly resistant 
mosquitoes, which can reduce their blood-feeding 
success. Using transmission models to explore these 
phenomena reveals that even small effects can aggregate 
over the lifetime of a mosquito to substantially reduce 
malaria transmission potential of resistant mosquitoes.10 
Further more, WHO bioassays should be done at 
25 oC ± 2 oC.28 At over 30oC, temperatures frequently found 
in African houses, pyrethroid-resistant mosquitoes can 
become more susceptible.31 These findings suggest that 
although standard assays might be valuable as resistance 
surveillance tools, they provide little insight into the 
functional significance of this resistance. Therefore, 
simply characterising a population as resistant according 
to the WHO test criteria does not mean there are 
necessarily any consequences for the effectiveness 
of ITNs.
The evidence suggests that in spite of widespread 
resistance, pyrethroid-treated nets remain an important 
intervention against malaria in sub-Saharan Africa. 
This observation does not mean that resistance has no 
effect; some of the data referred to above suggest that 
resistance-breaking insecticide mixtures on nets do 
provide improved protection compared with standard 
nets (although as we indicate it is possible to explain this 
without necessarily invoking resistance). Nonetheless, 
the epidemiological effect size appears small and we 
question whether our understandable concern about 
insecticide resistance has distracted attention from other 
aspects of ITNs and their use that are potentially more 
important in limiting effect of ITNs, such as inadequate 
funding leading to declining access to and use of nets, 
product quality and basic bioefficacy, net durability, and 
residual transmission.
ITN effective coverage, bioefficacy, fabric 
integrity, and residual transmission
A principal aim of ITN distribution programmes is to get 
at least 80% of the at-risk population sleeping under a 
net. With high ITN coverage, daily survival of vectors 
reduces substantially providing a community effect32-34 
that will reduce the number of infective mosquitoes and 
thereby protect non-net users, as well as ITN users. 
Unfortunately, the main reason that nets appear to fail in 
so many places is because people do not have access to a 
net. In 2019, only 36% of households had at least one net 
for every two persons, and 52% of people in at-risk areas 
had access to a net.1 Worryingly, net coverage peaked 
in 2017, and has declined thereafter (figure A). Moreover, 
ITN coverage is highly heterogeneous across the region 
(figure B). Because of the decline in coverage of 
protection against malaria in at risk populations, it is 
Panel 2: How insecticide-treated bednets work
Bednets work by providing a physical barrier to reduce mosquito–human contact and 
successful blood feeding. This is true whether the net is treated with insecticides or not. 
Adding insecticides provides additional protection in at least three ways. First, contact 
with the insecticide can kill the mosquito or rapidly disorient it, reducing the potential for 
mosquitoes to keep searching around the net and potentially feed on a human that might 
inadvertently have part of their body resting against the net as they sleep. Second, the 
death or impairment reduces the chances of the mosquito getting into a net, if the net is 
not properly tucked in under a mattress, or through a hole when the net inevitably 
becomes damaged. Third, killing or disorienting mosquitoes prevents them from going 
on to bite people who do not have nets or at times when people are not using nets. This 
latter effect can provide a level of community protection above and beyond the personal 
protective effects as long as effective coverage is high enough. Other effects might result 
from these primary effects (especially at high insecticide-treated bednets coverage), 
including reductions in density of adult mosquitoes or changes in mosquito population 
age structure. Skewing age structure towards younger mosquitoes can have a marked 
effect on transmission potential because it typically takes around 10–12 days for malaria 
parasites to complete development within the mosquito after an initial infectious blood 
meal. Repeat exposure to insecticide-treated bednets over successive blood feeding cycles 
reduces the proportion of mosquitoes that live long enough to successfully incubate the 
parasite, this can reduce transmission potential even if overall mosquito density remains 
relatively unchanged. Sublethal effects such as reduced feeding propensity, reduced 
host-searching capacity, or delayed mortality could also accrue following initial insecticide 
exposure; such effects might be important in contributing to control of mosquitoes that 
exhibit reduced mortality due to resistance.
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surprising that the downward trends in malaria case 
numbers and deaths have not started to reverse. The 
reason for this decline in coverage is that funding 
for malaria control globally has stagnated at about 
US$3 billion per year since 2012, whereas populations at 
risk and unit costs increased. It is remarkable how much 
has been achieved with this rather modest spending on a 
major global disease. Unsurprisingly, the COVID-19 
pandemic has led to major disruptions in malaria control 
in 2020,35,36 and this is likely to continue until vaccines are 
rolled out globally.
Adequate numbers of nets means at least one net 
shared between no more than two people. Assuming 
this metric is a realistic measure of access, in larger 
households with many adults and teenagers, one net per 
two people will be inadequate. It is also compounded by 
the notoriously difficult task of determining whether 
people actually sleep under a net or not. Self-reporting 
is likely to overestimate actual net usage. Therefore, 
coverage is not just an issue about a person having access 
to a net, but it is also whether they will use the net or not. 
The most common reasons for not using a net are that 
there are too few nets in the household, sleeping under a 
net feels too hot, or there are too few mosquitoes to 
bother.37 Bedrooms can be cooled by installing at least 
two large, screened windows in opposite walls.38 Low net 
use when mosquito densities are low is a challenge if 
malaria elimination is the goal. A study in Uganda39 
showed after a major reduction in malaria caused by a 
combination of IRS and ITNs, non-adherence to net use 
and ITNs was more common when mosquito numbers 
were low; in poorer households; and in households with 
children, particularly those of school age, which is the 
population that harbour the most malaria parasites. 
Health promotion targeted at this age group could help 
reduce the burden of malaria further. In parts of 
sub-Saharan Africa, insecticide resistance in bedbugs 
lowers compliance,40,41 so bedbug control with alternative 
products42 could increase coverage. These examples serve 
to illustrate the importance of understanding local 
obstacles to effective coverage. To increase access to and 
use of nets, deployment needs to be adapted to local 
conditions.
Of major concern is the deployment of sub-standard 
ITNs. A study43 from Papua New Guinea, where vectors 
remain susceptible to pyrethroids, investigated the 
relative effect of ITNs manufactured from 2007 to 2019 
on local vectors.43 All nets manufactured from 2007 
to 2012 met the required WHO standard of knockdown 
and killing, compared with only 17% of nets manufactured 
from 2013 to 2019. The authors suggested that malaria 
resurgence in Papua New Guinea might be due to sub-
standard nets used after 2013. Papua New Guinea is not 
alone in being supplied sub-standard nets, as they have 
also been reported in Burkina Faso in 2010,44 in the 
Solomon Islands in 2014,45 and Rwanda in 2015.46
For ITN brands to be approved for malaria control they 
must be evaluated by WHO’s prequalification team 
(previously named WHO’s Pesticide Evaluation Scheme). 
20 brands of long-lasting insecticidal nets are currently 
prequalified as vector control products by WHO. 
Insecticidal nets are classified as long-lasting insecticidal 
nets if: (1) a net washed 20 times results in 80% or higher 
mortality or 95% or higher knockdown in WHO cone 
tests, (2) they are not inferior to a reference net when 
washed 20 times in terms of blood-feeding inhibition 
and mortality in experimental huts, and (3) they are 
effective for at least 3 years in the field (ie, in serviceable 
condition passing bioefficacy and fabric integrity 
criteria).47 In practice, most nets do not last 3 years in 
the field. Net surveys in 13 countries indicate median 
functional survivorship of 40% (IQR 33–55; n=9), 
36 months after deployment (table). These findings 
suggest that more than half of nets fail long before they 
are replaced and there are too few people with access to 
effective ITNs. The real-world durability data suggest the 
need for improved product testing and rigorous quality 
Figure: ITNs coverage in sub-Saharan Africa
(A) Graph showing the proportion of households with one net for every 
two people from 2000 to 2019. (B) Map of Africa showing distribution of 
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assurance to maintain performance. There are currently 
very few data on the durability of new multiple insecticide 
nets under real-life conditions,53 and their potential 
superiority over standard nets might be only transient 
if they fail too quickly under conditions of everyday 
wear and tear. There has been a recent appeal to develop 
more durable mosquito nets,54 which we strongly 
endorse. Companies should be incentivised to develop 
more durable nets and provide evidence from the field 
supporting their claims. Although the unit price of more 
durable nets might exceed that of their more flimsy 
counterparts, the cost per year of protection could 
probably make them more cost-effective.
It is also important to reemphasise the interaction 
between coverage and bioefficacy, which links to the 
functional significance of insecticide resistance discussed 
earlier.10 If there is high effective coverage then even a 
relatively ineffective net (one that is less insecticidal, 
such as could occur with resistance) can still be effec-
tive at reducing community transmission. Alternatively, 
lower coverage of highly insecticidal nets can achieve the 
same result. The worst scenario is low coverage of weakly 
insecticidal nets.
The antimalarial efficacy of ITNs is primarily 
dependent on their ability to protect people when they 
are indoors and in bed. Mosquito biting that takes place 
outdoors either because mosquitoes take blood meals in 
the early evening before people are in bed, or because of 
changes in human night-time behaviour, contributes 
to residual transmission which limits the effectiveness 
of vector control with ITNs. A systematic review55 of 
mosquito and human behaviour concluded that although 
most biting by major malaria vectors occurred during 
times when people are in bed and hence able to protect 
themselves by means of an ITN, the proportion of 
transmission due to outdoor biting has increased 
since 2000. Much of this outdoor transmission is the 
result of changes in human behaviour related to certain 
occupations, sociocultural events, entertainment, house-
hold chores, and sleeping outdoors during travel.56,57 
Residual transmission has been noted to limit the 
maximum effectiveness of both ITNs and indoor residual 
spraying, even in settings where they have been deployed 
to scale.58,59 Elimination of malaria might therefore be 
dependent on the development, evaluation, and 
implemen tation of new classes of vector control tools 
that can better control both indoor and outdoor 
transmission. Such new tools might be especially 
important in situations where behavioural resistance has 
evolved, wherein mosquito populations exhibit a shift in 
biting or resting behaviour thereby reducing their 
exposure to indoor interventions such as ITNs and 
indoor residual spraying.60-62
Recommendations
We suggest six recommendations for improving the 
effectiveness of ITNs. First, WHO should establish a 
mechanism for the post-market monitoring of approved 
ITNs to ensure ITN quality is maintained. Second, 
national malaria control programmes should evaluate 
the functional quality of nets with each large consign-
ment of ITNs. Third, head-to-head comparisons of 
different ITN brands should be done regularly, 
with different net brands randomly distributed among 
the study population.52 Fourth, when awarding grants 
for purchasing ITNs, The Global Fund to Fight AIDS, 
Location Insecticide-treated 
net brand







Mansiangi and colleagues, 202048 Burkina Faso Olyset Permethrin 12% 36
Mansiangi and colleagues, 202048 Democratic Republic of the Congo DuraNet Alpha-cypermethrin 37% 31
Abílio and colleagues, 202049 Democratic Republic of the Congo DawaPlus 2.0 Deltamethrin 17% 31
Abílio and colleagues, 202049 Inhambane, Mozambique Royal Sentry Alpha-cypermethrin 57% 36
Abílio and colleagues, 202049 Nampula, Mozambique Royal Sentry Alpha-cypermethrin 33% 36
Obi and colleagues, 202050 Tete, Mozambique MAGNet Alpha-cypermethrin 43% 36
Obi and colleagues, 202050 Ebonyi, Nigeria DawaPlus 2.0 Deltamethrin 55% 36
Obi and colleagues, 202050 Oyo, Nigeria DawaPlus 2.0 Deltamethrin 75% 24
Obi and colleagues, 202050 Zamfara, Nigeria DawaPlus 2.0 Deltamethrin 80% 36
Haji and colleagues, 202051 Tanzania Olyset Permethrin 55% 33
Haji and colleagues, 202051 Tanzania PermaNet 2.0 Deltamethrin 51% 33
Lorenz and colleagues, 202052 Tanzania Olyset Permethrin 27% 36
Lorenz and colleagues, 202052 Tanzania PermaNet 2.0 Deltamethrin 38% 36
Lorenz and colleagues, 202052 Tanzania NetProtect Deltamethrin 40% 36
*Number of months after deployment functional survivorship reported. †Functional survivorship is the proportion of nets in serviceable condition, excluding those lost by 
attrition. Months when net first fails WHO bioefficacy criteria (≥80% mortality or ≥95% knockdown).
Table: Nets serviceable after 2–3 years of use
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Tuberculosis and Malaria should use a metric that 
includes net coverage and access, and length of 
protection offered, not just cost price of nets, thereby 
incentivising manufacturers to improve the quality and 
durability of nets. Fifth, academics and policy makers 
should look beyond insecticide resistance as a threat 
to malaria control and consider effective coverage, 
bioefficacy, net durability, and residual transmission. 
Last, global funding for malaria control needs to 
increase substantially to not only keep pace with 
population growth in malaria endemic countries and 
inflation of costs of malaria commodities, but also to get 
back on track with the targets set by the WHO Global 
Technical Strategy.
Conclusions
There is limited evidence, at present, that insecticide 
resistance in relation to ITN use is primarily responsible 
for the failure to effectively control or eliminate malaria in 
sub-Saharan Africa. Resurgence of malaria is more likely 
to be the result of inadequate funding leading to low net 
coverage and use, reduced bioefficacy of standard nets, 
poor and possibly deteriorating net durability, and 
increased risk of infection due to changing human and 
mosquito behaviour. New generation bednets using 
chemical combinations look promising and provide better 
protection against malaria than standard pyrethroid only 
nets. Importantly, we should explore novel ways for 
improving net coverage and carry out quality control after 
market approval to ensure that standards of ITNs are 
maintained in the field. Improved net durability needs to 
be urgently addressed, even if higher quality nets are 
more expensive. National control programmes are 
encouraged to develop novel ways to increase net use and 
identify sub-standard ITNs. Insecticide resistance is only 
one of the threats to effective malaria control with ITNs, 
and possibly not the most pressing one.
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